Hester Biosciences in talks with Bharat Biotech for production of vaccine
The discussions are currently ongoing with Bharat Biotech towards reviewing the infrastructure at Hester, the technology adaption process and the regulatory compliances.
New Delhi: Hester Biosciences on Sunday said it has tied up with the Gujarat government to explore production of COVID-19 vaccine through technology transfer from Bharat Biotech.
The Ahmedabad-based firm said it has already initiated the discussions with Bharat Biotech in this regard.
“A triparty consortium has been formed with the Government of Gujarat as the lead partner, to explore the prospects of manufacturing the Covid vaccine through technology from Bharat Biotech,” Hester Biosciences CEO and MD Rajiv Gandhi said in a statement.
The discussions are currently ongoing with Bharat Biotech towards reviewing the infrastructure at Hester, the technology adaption process and the regulatory compliances, he added.
Hester Biosciences is a leading player in the animal healthcare segment. It is the second largest poultry vaccine manufacturer in the country.
Only three vaccines have so far been approved to be sold in India — Covaxin, Covishield and Sputnik V.
Sputnik V has been approved to be imported from Russia by Dr Reddy’s, but is yet to be widely available in the country.
Now you can get handpicked stories from Telangana Today on Telegram everyday. Click the link to subscribe.
Click to follow Telangana Today Facebook page and Twitter .
